Finland· FI-REL-REL24721
Bondenza
A ibandronic acid product containing ibandronate sodium monohydrate, registered in Finland by Roche Registration Limited. The same ATC class is registered in 16 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Ibandronic acid is registered in 16 of 19 countries.
Countries holding a registration under ATC M05BA06 (ibandronic acid), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 10 of them publish a price we can compare per daily dose
Ibandronic acid · ATC M05BA06
16 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ibandronic acid costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.089 in United States to $1.30 in Switzerland — a ×15 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Ibandronic acid · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.30
- ES Spain$0.49
- IT Italy$0.38
- US United States$0.089 (acquisition cost)
The record
At a glance
Fimea (Finland)- Active substance
- Ibandronate sodium monohydrate
- Manufacturer
- Roche Registration Limited
- Country
- Finland (FI)
- ATC code
- M05BA06
- ATC class
- Ibandronic acid
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
228 interactions on record for ibandronic acid.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ibandronic acid · interactions on record
228 records
- 12 severe
- 98 moderate
- 94 info
Most severe, free to view
- EtelcalcetideH05BX04severe
- SirolimusL01EG04severe
- SirolimusL04AA10severe
- TacrolimusL04AD02severe
24 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ibandronic acid in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBONVIVAAtnahs Pharma Netherlands B.V., Amsterdam
- BelgiumIbandronic Acid Chemi 3 mgChemi
- United StatesIbandronate sodiumDr. Reddy's Laboratories Limited
- GermanyAscendraAnwerina Deutschland Gmbh
- IrelandIbandronic Acid 150 mg film-coated tabletsAccord Healthcare Ireland Ltd.
- SwedenEtanorden 150 mg Filmdragerad tablettGedeon Richter Plc
- IcelandIbandronic acid WHWilliams & Halls ehf
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Ibandronsäure +pharma, Ibandronsäure Actavis
- Czechia · Ibandronic Acid Viatris
- Germany · Ascendra, Ibandronsäure Al
- United Kingdom (Northern Ireland) · Ibandronic Acid Noridem Enterprises
- Greece · Ibondem
- Croatia · Ostea
- Hungary · Bonessa, Etanorden
- Ireland · Ibandronic Acid Noridem Enterprises
- Iceland · Ibandronic Acid Wh
- Italy · Acido Ibandronico Mylan
- Latvia · Ossica
- Netherlands · Ibandroninezuur Synthon
- Poland · Ibandronic Acid Noridem, Osagrand
- Portugal · Ácido Ibandrónico Gedeon Richter
- Romania · Ossica
- Sweden · Ibandronate Bluefish
- Slovakia · Ossica
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aabe8ad9-861a-41e3-82ce-74691e4e3391 GET /v1/drugs/aabe8ad9-861a-41e3-82ce-74691e4e3391?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "6",
"form": "injektioneste, liuos",
"route": null,
"ddd_unit": "mg",
"strength": "3 mg",
"atc_label": "ibandronihappo",
"ma_number": null,
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": "EU/1/03/266/005-006",
"fimea_rel_id": "REL24721",
"authorised_at": "2006-03-29"
}See everything about ibandronic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.